Sinovac Biotech Ltd. (NASDAQ:SVA) a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines for hepatitis A, hepatitis B, and influenza viruses announced preliminary top-line data from its Phase III clinical trial assessing the efficacy, immunogenicity and safety of the co's proprietary Enterovirus 71 ("EV71") vaccine against hand, foot and mouth disease. Sinovac Biotech Ltd. (NASDAQ:SVA) stock is reacting favorably to this news and as of this writing it's currently up (+38.24%) which has prompted Growing Stock Report to add it to their Nasdaq BioStock Watch List.
To see what other Investors are saying about Sinovac Biotech Ltd. (NASDAQ:SVA)
Click Here: http://www.growingstockreport.com/Survey.aspx?stock=SVA&SubId=AW
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease announced this morning that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the upcoming 25th Annual ROTH Conference, to be held March 17th -20th in Dana Point, California. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) has completed a U.S.-based Phase 3 clinical program for Zerenex for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease, conducted pursuant to a Special Protocol Assessment (SPA) agreement with the FDA, and Keryx expects to submit a New Drug Application with the FDA in the second quarter of 2013 and a Marketing Authorization Application with the EMA in mid-2013. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) is currently up (+468.75%) from it's 52 week low of $1.28 which has prompted Growing Stock Report to add the stock to their BioStock Watch List
To see what other Investors are saying about Keryx Biopharmaceuticals Inc. (NASDAQ:KERX)
Click Here: http://www.growingstockreport.com/Survey.aspx?stock=KERX&SubId=AW
Also added to the BioStock Watch was Baxter International Inc. (NYSE:BAX) which is currenly up (+42.92%) from it's 52 week low of $48.98 and trading around it's 52 week High of $70.53 which has prompted Growing Stock Report to add the stock to their Watch List.
To see what other Investors are saying about Baxter International Inc. (NYSE:BAX)
Click Here: http://www.growingstockreport.com/Survey.aspx?stock=BAX&SubId=AW
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Contact Info:Growing Stock Reporteditor@GrowingStockReport.com
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here